Clinical Trial Update: Lcr35 / ICU / P. Aeruginosa [NA]

View source ↗

Summary

A clinical trial evaluating Lcr35 in ICU patients with Pseudomonas infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Infections

Drugs mentioned

• Lcr35 (Lactobacillus rhamnosus GG (Lcr35 strain))

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Pseudomonas Infections | NA | Status: TERMINATED